They also exhibit moderate hyperglycemia, impaired glucose‐induced insulin secretion, glucose intolerance, peripheral IR, and chronic inflammation (Bisbis et al., 1993; Ostenson et al., 1993; Ouyang et al., 2019). This evidence concerns the gene INS and Glucose intolerance.